Cargando…
A novel paclitaxel coated balloon with increased drug transfer for treatment of complex vascular lesions
BACKGROUND: Drug coated balloons (DCB) with paclitaxel (Ptx) dose of 2–3.5 μg/mm(2) balloon surface inhibit restenosis with different effectiveness and duration of success. A clinical dose finding study is not known for any of the currently marketed products. The aim of the present preclinical trial...
Autores principales: | Gemeinhardt, Ole, Schnorr, Beatrix, Speck, Ulrich, Scheller, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555778/ https://www.ncbi.nlm.nih.gov/pubmed/34714843 http://dx.doi.org/10.1371/journal.pone.0259106 |
Ejemplares similares
-
One single drug-coated balloon for all shapes/diameters? Neointimal proliferation inhibition in porcine peripheral arteries
por: Bienek, Stephanie, et al.
Publicado: (2023) -
Improvement of Outcome for Treatment of ‘Restenosis-prone’ Vascular Lesions? Potential Impact of the Paclitaxel dose on Late Lumen Loss in Porcine Peripheral Arteries
por: Gemeinhardt, Ole, et al.
Publicado: (2022) -
Drug Distribution and Basic Pharmacology of Paclitaxel/Resveratrol-Coated Balloon Catheters
por: Speck, Ulrich, et al.
Publicado: (2018) -
Paclitaxel-Coated Balloons: Investigation of Drug Transfer in Healthy and Atherosclerotic Arteries – First Experimental Results in Rabbits at Low Inflation Pressure
por: Stolzenburg, Nicola, et al.
Publicado: (2016) -
Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
por: Her, Ae-Young, et al.
Publicado: (2016)